159 related articles for article (PubMed ID: 37814330)
1. Lipidome of mammographic breast density in premenopausal women.
Getz KR; Jeon MS; Luo C; Luo J; Toriola AT
Breast Cancer Res; 2023 Oct; 25(1):121. PubMed ID: 37814330
[TBL] [Abstract][Full Text] [Related]
2. Associations of Vitamins and Related Cofactor Metabolites with Mammographic Breast Density in Premenopausal Women.
Matthew KA; Getz KR; Jeon MS; Luo C; Luo J; Toriola AT
J Nutr; 2024 Feb; 154(2):424-434. PubMed ID: 38122846
[TBL] [Abstract][Full Text] [Related]
3. Breastfeeding and Mammographic Breast Density: A Cross-sectional Study.
Getz KR; Adedokun B; Xu S; Toriola AT
Cancer Prev Res (Phila); 2023 Jun; 16(6):353-361. PubMed ID: 36930943
[TBL] [Abstract][Full Text] [Related]
4. Adiposity at Age 10 and Mammographic Density among Premenopausal Women.
Alimujiang A; Imm KR; Appleton CM; Colditz GA; Berkey CS; Toriola AT
Cancer Prev Res (Phila); 2018 May; 11(5):287-294. PubMed ID: 29500187
[TBL] [Abstract][Full Text] [Related]
5. Coffee, Tea, and Mammographic Breast Density in Premenopausal Women.
Odama AM; Otti V; Xu S; Adebayo O; Toriola AT
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836118
[TBL] [Abstract][Full Text] [Related]
6. Adiposity during early adulthood, changes in adiposity during adulthood, attained adiposity, and mammographic density among premenopausal women.
Alimujiang A; Appleton C; Colditz GA; Toriola AT
Breast Cancer Res Treat; 2017 Nov; 166(1):197-206. PubMed ID: 28702890
[TBL] [Abstract][Full Text] [Related]
7. Plasma Growth Factor Gene Expression and Mammographic Breast Density in Postmenopausal Women.
Akinjiyan FA; Adams A; Xu S; Wang M; Toriola AT
Cancer Prev Res (Phila); 2022 Jun; 15(6):391-398. PubMed ID: 35288741
[TBL] [Abstract][Full Text] [Related]
8. Aspirin Metabolites and Mammographic Breast Density in Premenopausal Women.
Singh RK; Getz KR; Kyeyune JK; Jeon MS; Luo C; Luo J; Toriola AT
Cancer Epidemiol Biomarkers Prev; 2024 May; ():. PubMed ID: 38700429
[TBL] [Abstract][Full Text] [Related]
9. Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women.
Han Y; Moore JX; Colditz GA; Toriola AT
JAMA Netw Open; 2022 Feb; 5(2):e2148983. PubMed ID: 35175341
[TBL] [Abstract][Full Text] [Related]
10. Medication use and mammographic breast density.
Han Y; Lee CT; Xu S; Mi X; Phillip CR; Salazar AS; Rakhmankulova M; Toriola AT
Breast Cancer Res Treat; 2021 Sep; 189(2):585-592. PubMed ID: 34196899
[TBL] [Abstract][Full Text] [Related]
11. Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal Women.
Toriola AT; Appleton CM; Zong X; Luo J; Weilbaecher K; Tamimi RM; Colditz GA
Cancer Prev Res (Phila); 2018 Dec; 11(12):789-796. PubMed ID: 30352839
[TBL] [Abstract][Full Text] [Related]
12. Milk intake and mammographic density in premenopausal women.
Han Y; Zong X; Li Y; Colditz GA; Toriola AT
Breast Cancer Res Treat; 2019 Feb; 174(1):249-255. PubMed ID: 30456438
[TBL] [Abstract][Full Text] [Related]
13. Lifetime changes in body fatness and breast density in postmenopausal women: the FEDRA study.
Masala G; Bendinelli B; Caini S; Duroni G; Ermini I; Pastore E; Fontana M; Facchini L; Querci A; Gilio MA; Mazzalupo V; Assedi M; Ambrogetti D; Palli D
Breast Cancer Res; 2023 Mar; 25(1):35. PubMed ID: 37004102
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of volumetric breast density and body mass index on breast cancer risk.
Engmann NJ; Scott CG; Jensen MR; Winham S; Miglioretti DL; Ma L; Brandt K; Mahmoudzadeh A; Whaley DH; Hruska C; Wu F; Norman AD; Hiatt RA; Heine J; Shepherd J; Pankratz VS; Vachon CM; Kerlikowske K
Breast Cancer Res Treat; 2019 Aug; 177(1):165-173. PubMed ID: 31129803
[TBL] [Abstract][Full Text] [Related]
15. Predictors of mammographic density among women with a strong family history of breast cancer.
Moran O; Eisen A; Demsky R; Blackmore K; Knight JA; Panchal S; Ginsburg O; Zbuk K; Yaffe M; Metcalfe KA; Narod SA; Kotsopoulos J
BMC Cancer; 2019 Jun; 19(1):631. PubMed ID: 31242899
[TBL] [Abstract][Full Text] [Related]
16. Adjusting for BMI in analyses of volumetric mammographic density and breast cancer risk.
Hudson S; Vik Hjerkind K; Vinnicombe S; Allen S; Trewin C; Ursin G; Dos-Santos-Silva I; De Stavola BL
Breast Cancer Res; 2018 Dec; 20(1):156. PubMed ID: 30594212
[TBL] [Abstract][Full Text] [Related]
17. The FEDRA Longitudinal Study: Repeated Volumetric Breast Density Measures and Breast Cancer Risk.
Masala G; Assedi M; Bendinelli B; Pastore E; Gilio MA; Mazzalupo V; Querci A; Fontana M; Duroni G; Facchini L; Saieva C; Palli D; Ambrogetti D; Caini S
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980696
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials.
Salazar AS; Rakhmankulova M; Simon LE; Toriola AT
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33554041
[TBL] [Abstract][Full Text] [Related]
19. Association of the Interaction Between Mammographic Breast Density, Body Mass Index, and Menopausal Status With Breast Cancer Risk Among Korean Women.
Tran TXM; Moon SG; Kim S; Park B
JAMA Netw Open; 2021 Dec; 4(12):e2139161. PubMed ID: 34940866
[TBL] [Abstract][Full Text] [Related]
20. Hormone and receptor activator of NF-κB (RANK) pathway gene expression in plasma and mammographic breast density in postmenopausal women.
Mintz R; Wang M; Xu S; Colditz GA; Markovic C; Toriola AT
Breast Cancer Res; 2022 Apr; 24(1):28. PubMed ID: 35422057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
